(Q73135212)
Statements
Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trial (English)
M Kaufmann
E Bajetta
L Y Dirix
L E Fein
S E Jones
J Cervek
C Fowst
A Polli
E Di Salle
G Massimini
1 September 2000